Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 5c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• M-tron Industries, Inc. (MPTI) Misses Q2 EPS by 10c